Transfusion practice, post-transfusion complications and risk factors in sickle cell disease in senegal, west africa.

Conclusion: Despite advances in blood safety, BT therapy is still a risk for SCD polytransfused patients. Although infectious transmission has rare, the risk of alloimmunization and iron overload is high in these patients.

Source: Mediterranean Journal of Hematology and Infectious Diseases - January 1, 2022 Category: Hematology Authors: Moussa Seck, Alioune Badara Senghor, Mossane Loum, Sokhna Aissatou Tour é, Blaise Félix Faye, Alioune Badara Diallo, Mohamed Keita, Elimane Seydi Bousso, Sérigne Mourtalla Guèye, Macoura Gadji, Abibatou Sall, Awa Oumar Touré, Saliou Diop Source Type: research